Clinical trial
Feasibility of Retinoic Acid Treatment in Emphysema (FORTE)
NCT00000621 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00000621 |
|---|---|
| Title | Feasibility of Retinoic Acid Treatment in Emphysema (FORTE) |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Emphysema, Lung Diseases, Obstructive, Chronic Obstructive Pulmonary Disease |
| Intervention type | Drug |
| Interventions | all trans retinoic acid, 13 cis retinoic acid, placebo |
| Start date | Sep 1, 1999 |
| Primary completion | Dec 1, 2004 |
| Completion | Dec 1, 2004 |
| First posted | Oct 28, 1999 |
| Last update posted | Jan 16, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: